🤯Take a deep dive on the tiny #microbes living around us, and how they shape our health & planet 🤯
Join us today *1PM EST* for the @GairdnerAwards Global Perspectives Panel Discussion on The #Microbiome: From Planetary🌎 to Microbial🦠 Scale!
Free: https://t.co/5BWKDDeYQb
DAY 1 NIF RECAP 3/3: Our wonderful CIHR-III NIF 2024 participants! Thank you to all of our speakers, panellists, organizing committee, III staff and - of course - our 64 new investigators! @ckaushic#OurFutureOurIIINIF
Prof Christian Happi & the entire ACEGID team mourn the passing of Dr Herbert Wigwe.
Dr Wigwe was a huge supporter of our work @acegid. Through his leadership, @myaccessbank funded the solar power system of our Genomics Centre, facilitating our exit from the national grid.
RIP!
Appili Announces @US_FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension
"Appili was formed to develop ATI-1501, and we are delighted to see our first development project make it to market" Appili President & CEO @drugdrdon
$APLI $APLIF
https://t.co/PKm7wifYZA
Congratulations to the winners of the 2023 Gairdner Early Career Investigators (ECI) competition! These 5 investigators will present their research alongside the 2023 #GairdnerAwards laureates during #GairdnerScienceweek in October.
Learn more ➡️ https://t.co/aqChhxPmvC
Congratulations to Dr. Abiola Olaitan!
Dr. Olaitan will present "How Clostridioides difficile hijacks heme to mediate metronidazole resistance" during the Laureate Lectures on Oct. 26.
Details ➡️ https://t.co/qWz2vrWUNw
Getting excited for #ClostPath2023! Registration for the conference begins in less than one month! Key dates and more information can be found here:
https://t.co/2gc8JLnfxw
Since the early 2000s, Metronidazole has mostly failed in CDI treatment. Other treatment options cost at least 60x more (Metronidazole $21; Vancomycin $1,400; Fidaxomicin $3,360). Why has Metronidazole failed?
Our recent publication addressing this:bioRxiv https://t.co/ebHIfh04dg
@BajraiLeena Hi Leena, nice to connect with you on twitter. I remember our days at Aix-Marseille University in France. Congrats on your new achievements and discoveries. Stay in touch.
Nice to be part of an incredible team working to address C. difficile infection and drug development!
Drug development is a multipronged process, including testing drug efficacy using different microbiological media. This is often…https://t.co/FtF72buBUr https://t.co/reotE4l7HA
Armand Balboni, I quite agreed with the points you raised in this write-up. Considering the rate at which COVID-19 is mutating and continuous economic burden, they should be a strategic plan to stay on top of the situation. This should involve developing…https://t.co/7bsbSp87Jd
A common fear of hospitalized patients worldwide is contracting Clostridium difficile infection (CDI), which can be difficult and costly to treat due to treatment failure.
It's great to be part of this groundbreaking study that fi…https://t.co/ykeTXpVu8p https://t.co/byaJvGXKcM
@TundeTASH@CNN@CP24 @AlJazeera_World @BBCWorld The white in Nigerian flag is turning RED!!! Military are shooting at protesters at Lekki toll gate at the moment! 😭😭😭